MedTrace Logo

Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

NCT00484107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2007-12-28

No results posted yet for this study

Summary

This post-marketing study will provide local safety and tolerance data on the use of Premarin® vaginal cream.

Conditions

  • Postmenopause

Interventions

DRUG

Conjugated Estrogen Cream (Premarin®)

Sponsors & Collaborators

  • Wyeth is now a wholly owned subsidiary of Pfizer

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2006-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00484107 on ClinicalTrials.gov